SCHEMBL168203

SCHEMBL168203

COc1c(C(N)=O)n[nH]c1-c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43
TUBB6 Q9BUF5 1/20 0.43
TUBB2B Q9BVA1 1/20 0.43
TUBB1 Q9H4B7 1/20 0.43
HAO2 Q9NYQ3 1/20 0.40
NTRK1 P04629 1/20 0.40
SQOR Q9Y6N5 1/20 0.39
CDC7 O00311 1/20 0.39
FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167755 0.85 IRAK4 (0.39) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL164284 0.84 MAPK1 (0.39) HAO2NTRK1SQORFYNMAPT
SCHEMBL10642212 0.76 LMNA (0.44) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL29720381 0.74 MEN1 (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL166629 0.73 CDC7 (0.39) CDC7MAPTTHRBLMNATP53
SCHEMBL20307767 0.71 MAPT (0.46) MAPTLMNATP53HTTMAPK10
SCHEMBL20074772 0.70 HAO2 (0.42) HAO2MAPTMAPK14
SCHEMBL29812239 0.70 MAPT (0.42) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3120716 0.70 MAPK13 (0.57) CDC7IKBKBMAPTLMNATP53
SCHEMBL4964605 0.70 HAO2 (0.53) HAO2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS Lead Discovery Center GmbH (DE) 2013-07-03 EP disclosed
WO-2012028332-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2012-03-08 WO disclosed